Sabino Riestra

12PUBLICATIONS
81CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nephrology and urologyCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 31, 2026
The Prevalence of Frailty in Elderly Inflammatory Bowel Disease Patients Varies Depending on the Scale Used.

|Jun 29, 2026
Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU.

|May 03, 2025
Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCU.

María José Casanova, Cristina Rubín de Célix, Sabino Riestra

|Sep 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

María Chaparro, Sandra Hermida, Diana Acosta

|Mar 06, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).

María José García, Sabino Riestra, Aurelien Amiot

|Jul 31, 2023
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.

María José García, Montserrat Rivero, Agnès Fernández-Clotet

Pageof 2

Frequent Collaborators

8 joint publications

María Chaparro

8 joint publications

Javier P Gisbert

4 joint publications

Jose Maria Huguet

3 joint publications

Margalida Calafat